Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Barry

Showing results (281-290 of 420) with videos related to

Pageof 42
Sort By:
Journal of Clinical Microbiology|August 1, 1985
Proposed disk diffusion susceptibility criteria for ofloxacinP C Fuchs, A L Barry, R N Jones, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1981
In vitro antimicrobial activity evaluation of cefodizime (HR221), a new semisynthetic cephalosporinR N Jones, A L Barry, C Thornsberry, et al.
Cleveland Clinic Quarterly|January 1, 1980
In vitro activity of mezlocillin and azlocillin compared with that of four other penicillins and two aminoglycosidesA L Barry, C Thornsberry, R N Jones, et al.
Clinical Therapeutics|January 1, 1980
Cefoperazone: evaluation of the in vitro activity and an analysis of the disk diffusion testC Thornsberry, C N Baker, A L Barry, et al.
American Journal of Clinical Pathology|April 1, 1981
Gentamicin, tobramycin, and sisomicin disc susceptibility tests. Revised zone standards for interpretationA L Barry, C Thornsberry, R N Jones, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1980
Interpretive standards for disk susceptibility tests with Sch 21420 and amikacinA L Barry, C Thornsberry, R N Jones, et al.
Journal of Clinical Microbiology|August 1, 1986
Disk diffusion susceptibility testing of two macrolide antimicrobial agents: revised interpretive criteria for erythromycin and preliminary guidelines for roxithromycin (RU 965)R N Jones, A L Barry, P C Fuchs, et al.
American Journal of Clinical Pathology|October 1, 1985
The cefoperazone-sulbactam combination. In vitro qualities including beta-lactamase stability, antimicrobial activity, and interpretive criteria for disk diffusion testsR N Jones, A L Barry, C Thornsberry, et al.
American Journal of Clinical Pathology|October 1, 1982
Direct comparison of two mechanized systems for identification of gram-negative bacilli. Autobac ID system versus the auto microbic system (with EBC plus)A L Barry, T L Gavan, R E Badal, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1994
In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993A L Barry, M A Pfaller, P C Fuchs, et al.
Pageof 42

Showing results (281-290 of 420) with videos related to

Sort By:
Pageof 42
Journal of Clinical Microbiology|August 1, 1985
Proposed disk diffusion susceptibility criteria for ofloxacinP C Fuchs, A L Barry, R N Jones, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1981
In vitro antimicrobial activity evaluation of cefodizime (HR221), a new semisynthetic cephalosporinR N Jones, A L Barry, C Thornsberry, et al.
Cleveland Clinic Quarterly|January 1, 1980
In vitro activity of mezlocillin and azlocillin compared with that of four other penicillins and two aminoglycosidesA L Barry, C Thornsberry, R N Jones, et al.
Clinical Therapeutics|January 1, 1980
Cefoperazone: evaluation of the in vitro activity and an analysis of the disk diffusion testC Thornsberry, C N Baker, A L Barry, et al.
American Journal of Clinical Pathology|April 1, 1981
Gentamicin, tobramycin, and sisomicin disc susceptibility tests. Revised zone standards for interpretationA L Barry, C Thornsberry, R N Jones, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1980
Interpretive standards for disk susceptibility tests with Sch 21420 and amikacinA L Barry, C Thornsberry, R N Jones, et al.
Journal of Clinical Microbiology|August 1, 1986
Disk diffusion susceptibility testing of two macrolide antimicrobial agents: revised interpretive criteria for erythromycin and preliminary guidelines for roxithromycin (RU 965)R N Jones, A L Barry, P C Fuchs, et al.
American Journal of Clinical Pathology|October 1, 1985
The cefoperazone-sulbactam combination. In vitro qualities including beta-lactamase stability, antimicrobial activity, and interpretive criteria for disk diffusion testsR N Jones, A L Barry, C Thornsberry, et al.
American Journal of Clinical Pathology|October 1, 1982
Direct comparison of two mechanized systems for identification of gram-negative bacilli. Autobac ID system versus the auto microbic system (with EBC plus)A L Barry, T L Gavan, R E Badal, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1994
In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993A L Barry, M A Pfaller, P C Fuchs, et al.
Pageof 42